Sanofi trims lending group for €3bn RCF
Sanofi-Aventis, the pharmaceutical firm, has managed to cut the size of the bank group on its new €3bn facility, but demand for the A1/AA-/AA- rated company’s paper has meant that some banks have also joined the syndicate.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
